Published in Clin Cancer Res on February 17, 2009
Accuracy of detection of high-grade cervical intraepithelial neoplasia using electrical impedance spectroscopy with colposcopy. BJOG (2013) 0.82
The use of optical spectroscopy for in vivo detection of cervical pre-cancer. Lasers Med Sci (2013) 0.79
Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe data. J Biomed Opt (2012) 0.79
Increased detection of precancerous cervical lesions with adjunctive dynamic spectral imaging. Int J Womens Health (2017) 0.75
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res (2009) 2.32
Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev (2008) 2.20
Electrosurgical bipolar vessel sealing for vaginal hysterectomies. Arch Gynecol Obstet (2014) 2.00
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy. Cancer (2010) 1.71
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol (2012) 1.57
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res (2011) 1.28
Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study. Int J Cancer (2008) 1.27
Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab (2002) 1.20
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev (2004) 1.18
Management of ureteric injuries during gynecological operations: 10 years experience. Eur J Obstet Gynecol Reprod Biol (2002) 1.14
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update (2013) 1.13
Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol (2003) 1.11
Current treatment concepts for neuromas-in-continuity. Injury (2008) 1.08
Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears. J Med Virol (2010) 1.07
Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer. Am J Pathol (2009) 1.06
Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J Proteome Res (2008) 1.05
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. Int J Cancer (2011) 1.05
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas. BMC Cancer (2006) 1.04
Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? J Immunol (2013) 1.02
Endometrial cancer. BMJ (2011) 1.02
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunother (2013) 1.01
A novel spectral microscope system: application in quantitative pathology. IEEE Trans Biomed Eng (2003) 1.01
Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer (2011) 0.99
Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas. Cancer J (2006) 0.98
Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res (2006) 0.97
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. Breast Cancer Res Treat (2006) 0.97
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome. Breast Cancer Res (2006) 0.97
Vulvar angiokeratoma following radical hysterectomy and radiotherapy. Acta Obstet Gynecol Scand (2002) 0.96
The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditation. Int J Gynecol Cancer (2015) 0.95
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses. Gynecol Oncol (2013) 0.94
Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies. Lipids Health Dis (2011) 0.93
The shotgun proteomic study of the human ThinPrep cervical smear using iTRAQ mass-tagging and 2D LC-FT-Orbitrap-MS: the detection of the human papillomavirus at the protein level. J Proteome Res (2013) 0.92
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group. Clin Breast Cancer (2010) 0.91
Tumor seeding incidentally found two years after robotic-Assisted radical nephrectomy for papillary renal cell carcinoma. A case report and review of the literature. Int J Surg Case Rep (2013) 0.91
Needle versus loop diathermy excision of the transformation zone for the treatment of cervical intraepithelial neoplasia: a randomised controlled trial. BJOG (2004) 0.90
The poly(c)-binding protein-1 regulates expression of the androgen receptor. Endocrinology (2010) 0.90
Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer. BJOG (2004) 0.89
Characterization of adnexal masses with MRI. AJR Am J Roentgenol (2005) 0.89
Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype. APMIS (2007) 0.89
Castleman's disease associated with myasthenia gravis. Ann Thorac Surg (2003) 0.88
Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR Am J Roentgenol (2005) 0.87
The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Anticancer Res (2008) 0.87
Exogenous and autocrine growth factors stimulate human intervertebral disc cell proliferation via the ERK and Akt pathways. J Orthop Res (2011) 0.87
Immunohistochemical study of the angiogenetic network of VEGF, HIF1α, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer. Pathol Oncol Res (2011) 0.86
Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol Oncol (2006) 0.86
A study of symptoms described by ovarian cancer survivors. Gynecol Oncol (2011) 0.86
Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma. Pancreas (2007) 0.85
Metastatic cervical carcinoma to the thyroid gland: a case report and review of the literature. Yale J Biol Med (2006) 0.84
Miliary tuberculous peritonitis mimicking advanced ovarian cancer. Gynecol Obstet Invest (2003) 0.84
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes. Mod Pathol (2012) 0.83
Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics (2009) 0.83
1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed (2004) 0.83
An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis (2013) 0.83
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype. Cancer Detect Prev (2006) 0.83
Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers. Acta Obstet Gynecol Scand (2007) 0.82
Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed (2004) 0.82
Cervical cone measurements and residual disease in LLETZ conisation for cervical intraepithelial neoplasia. In Vivo (2011) 0.82
Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer. Anticancer Res (2008) 0.82
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials (2013) 0.82
IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer. Clin Cancer Res (2009) 0.81
Achieving uterine auto-transplantation in a sheep model using iliac vessel anastomosis: a short-term viability study. Acta Obstet Gynecol Scand (2014) 0.81
(1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load. J Magn Reson Imaging (2004) 0.81
Molecular characteristics and risk factors in endometrial cancer: what are the treatment and preventative strategies? Int J Gynecol Cancer (2010) 0.81
Nutritional, lifestyle, and weight control practices of professional jockeys. J Sports Sci (2011) 0.81
Histologic implications of Pap smears classified as atypical glandular cells. J Reprod Med (2005) 0.80
The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profiles. Am J Pathol (2013) 0.80
Feasibility, safety, and cost outcomes of laparoscopic management of early endometrial and cervical malignancy. JSLS (2010) 0.80
Expression profiling of vulvar carcinoma: clues for deranged extracellular matrix remodeling and effects on multiple signaling pathways combined with discrete patient subsets. Transl Oncol (2011) 0.80
Claudin-3 and claudin-4: distinct prognostic significance in triple-negative and luminal breast cancer. Appl Immunohistochem Mol Morphol (2014) 0.79
Coexistence of verrucous and squamous carcinoma of the vulva. Aust N Z J Obstet Gynaecol (2005) 0.79
Vascular endothelial growth factor protein expression in a renal ablation rabbit model under prolonged warm and cold ischemia. Am J Nephrol (2007) 0.79
Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. Am J Pathol (2010) 0.79
Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream. N Engl J Med (2002) 0.79
The need for more workshops in laparoscopic surgery and surgical anatomy for European gynaecological oncology trainees: a survey by the European Network of Young Gynaecological Oncologists. Int J Gynecol Cancer (2013) 0.79
Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer. BJU Int (2012) 0.79
Management of early-stage cervical carcinoma by modified (Type II) radical hysterectomy. Gynecol Oncol (2002) 0.79
Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas? Arch Gynecol Obstet (2012) 0.79
Effects of prolonged warm and cold ischemia in a solitary kidney animal model after partial nephrectomy: an ultrastructural investigation. Ultrastruct Pathol (2011) 0.79
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer. Int J Gynecol Cancer (2015) 0.78
Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia. Acta Obstet Gynecol Scand (2012) 0.78
Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells? Anticancer Res (2006) 0.78
A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. FASEB J (2011) 0.77
Intraneural OX7-saporin for neuroma-in-continuity in a rat model. Eur J Orthop Surg Traumatol (2012) 0.77
Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas. Arch Gynecol Obstet (2011) 0.77
A novel endoscopic spectral imaging platform integrating k-means clustering for early and non-invasive diagnosis of endometrial pathology. Conf Proc IEEE Eng Med Biol Soc (2013) 0.77
Role of chromosome 3q26 gain in predicting progression of cervical dysplasia. Int J Gynecol Cancer (2012) 0.77
A study to evaluate the cause of bone demineralization in gynecological cancer survivors. Oncologist (2013) 0.77